BioE: IMO if and when a current pharma partner extends the relationship substantially, it will be a trigger for VC funds.
To my knowledge the Pfiz animal trials are definitely still running. They were extended due to factors out of the control of either party. Both relationships Pfiz and Janss seem to be close.
And it's worth mentioning, any info I receive from Mgmt, I cross check with major shareholders.
My earlier post was concerning your lack of rant concerning PYC evolving the discovery platform to optimise the screening of the libraries to identify cell-specific peptides that can penetrate cell membranes.
SoT
BioE: IMO if and when a current pharma partner extends the...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 13.5¢ | $687.7K | 4.887M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 87494 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 2187900 | 13 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |